¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"monocyte chemotactic and activating factor"¿¡ ´ëÇÑ KI ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
monocyte
´Ü±¸, ´ÜÇÙ¼¼Æ÷
attenuation factor
°¨¾à¿ä¼Ò, °¨¼è¿äÀÎ
conversion factor
º¯È¯ÀÎÀÚ
factor
ÀÎÀÚ
predisposing factor
¼ÒÀÎ, Áúº´¼ÒÁú
Q factor
Å¥ÀÎÀÚ
rheumatoid factor
·ù¸¶Æ¼½º¾çÀÎÀÚ
risk factor
À§Çè¿äÀÎ
turbo factor
Åͺ¸ÀÎÀÚ
ball and socket joint
Àý±¸°øÀ̰üÀý
ENT [=ear, nose and throat]
À̺ñÀÎÈİúÇÐ
growth and development
¼ºÀå°ú ¹ßÀ°
infant and child
¿µÀ¯¾Æ, À¯¼Ò¾Æ
intake and output
¼·Ãë¿Í ¹è¼³
kidney ureter and bladder [=KUB]
½Å-´¢°ü-¹æ±¤ ´Ü¼øÃÔ¿µ
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½